Clinical Trial Update: Intermittent Fasting (IF) Has Gained Recognition as a Promising Weight Loss Approach That Improves Body Weight, Insulin Resistance, and Metabolism. While Standard Diets Are Common in PCOS Management, IF May Address the Underlying Causes of Weight Gain and Offer Additional Metabolic Benefits [NA]

View source ↗

Summary

This clinical trial update reports completion of a Bahçeşehir University study on intermittent fasting for weight loss and metabolic changes in individuals with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Snippet

Sponsor: Bahçeşehir University | Conditions: Polycystic Ovary Syndrome, Weight Loss | NA | Status: COMPLETED